CTRE stock forecast, quote, news & analysis

Key Takeaways

• CTRE shares have gained approximately 5% over the trailing 30 days, supported by robust Q1 2026 earnings, raised full-year guidance, and accelerating investment activity.
• CareTrust closed roughly $1.1 billion in year-to-date investments at a blended stabilized yield of approximately 8.9%, spanning U.S. skilled nursing, senior housing, U.K. care homes, and SHOP assets.
• Moody's upgraded the company to investment grade in the first quarter, broadening its access to debt capital and reinforcing balance-sheet strength.
• The quarterly dividend was increased 16.4% to $0.39 per share, with a conservative payout ratio of approximately 81% of Normalized FAD.
• Q2 2026 earnings are confirmed for July 30 after market close, with a consensus EPS estimate of $0.37.
• Analyst consensus stands at "Buy" with an average price target of $44.82, implying potential upside from current levels.

Current Market Snapshot

CareTrust REIT (CTRE) has maintained constructive momentum through mid-2026, with shares trading near $42.97 as of late July. The stock has recovered decisively from a mid-June dip that briefly pushed prices into the mid-$36 range, reclaiming ground above both the 50-day simple moving average of roughly $39.95 and the 200-day moving average of approximately $39.04. With a market capitalization near $10 billion and a 52-week range of $30.26 to $43.10, CTRE has delivered a resilient performance within the healthcare REIT sector. Institutional ownership stands at nearly 88%, reflecting sustained confidence from large investors including Bank of New York Mellon, which increased its position by 5.2% during the first quarter.

CareTrust REIT (CTRE) Business Overview and Competitive Position

CareTrust REIT is a self-administered, publicly traded real estate investment trust focused on the ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties. The company operates through a portfolio of long-term, triple-net leased properties spanning the United States and the United Kingdom, with a growing roster of quality operators as tenants. Its key competitive differentiators include a relationship-driven, off-market deal-sourcing strategy, a diversified investment approach across three growth engines — U.S. skilled nursing and senior housing triple-net investments, U.K. care homes, and senior housing operating properties (SHOP) — and a fortress balance sheet that provides flexibility to pursue large-scale transactions. With no scheduled debt maturities before 2028 and a $1.2 billion unsecured revolving credit facility, CareTrust has positioned itself as one of the more agile acquirers in the healthcare real estate space.

Recent Developments Driving CTRE

The most significant catalyst in recent months was the company's first-quarter 2026 earnings report released on May 7, which showcased normalized FFO of $0.48 per share — a 14% year-over-year increase — and normalized FAD of $0.48 per share, up 12%. Management raised full-year 2026 guidance to normalized FFO of $2.00 to $2.04 per share and normalized FAD of $1.98 to $2.02 per share, with midpoints implying increases of 14.8% and 13.6% respectively over 2025 results. The guidance raise was anchored by approximately $1.1 billion in year-to-date investments at a blended stabilized yield of roughly 8.9%.

Moody's upgrade of CareTrust to investment grade marked a pivotal milestone, lowering the company's cost of future debt capital and potentially opening the door to an inaugural high-grade bond issuance. On May 18, CareTrust priced an upsized public offering of 12.5 million shares through forward sale agreements, generating approximately $509.4 million in gross proceeds to fund the investment pipeline. The company also raised its quarterly dividend by 16.4% to $0.39 per share, underscoring management's confidence in earnings visibility.

Analyst sentiment has remained firmly positive. Mizuho set a $45 price target, KeyCorp reiterated Overweight with a $46 target, Raymond James initiated coverage with an Outperform rating and a $43 target, and Citigroup maintained a Market Outperform rating. Weiss Ratings upgraded CTRE to "Buy (a-)" in early July. The investment pipeline stood at approximately $360 million as of the Q1 call, with more than half in U.K. care homes and about 20% in SHOP opportunities.

Trending AI Robots

Investors seeking data-driven approaches to stock selection may find value in Tickeron's Trending AI Robots page, a curated hub showcasing top-performing AI trading bots from a broader universe of hundreds of automated strategies trading thousands of tickers. These bots employ diverse methodologies — ranging from short-term technical pattern recognition to longer-duration momentum and valuation-driven models — and vary by strategy, timeframe, and performance metrics. The Trending AI Robots section highlights only the most relevant and consistently performing bots, offering traders a practical starting point for exploring algorithmic trading without navigating the full library of available strategies.

2026 Outlook and What Investors Should Watch

The most immediate event on the horizon is CareTrust's Q2 2026 earnings report, confirmed for July 30 after market close. Analysts expect EPS of $0.37, and investors will scrutinize updates to the full-year guidance, the pace of post-Q1 investment activity, and any changes to the $360 million pipeline. The company's ability to deploy capital at attractive yields while maintaining underwriting discipline — particularly amid cap-rate compression in the SHOP segment — will be a key narrative. On the macro front, interest rate policy remains a critical variable for REIT valuations, as higher-for-longer rate expectations could pressure multiples across the sector. Currency exposure to the British pound through U.K. care home investments introduces an additional risk factor, though management has flagged this sensitivity in guidance assumptions. Demographic tailwinds from an aging population and steadily recovering skilled nursing occupancy rates provide a supportive long-term backdrop, but near-term execution on the growing pipeline and successful integration of recent acquisitions will likely determine CTRE's trajectory through the remainder of 2026.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations